Monoclonal gammopathy in human leishmaniasis

M L Randi; E Ruzzon; F Tezza; F Tezza; E Pacquola; F Fabris

Monoclonal gammopathy in human leishmaniasis

Neth J Med. 2006 Feb;64(2):50-1.

Authors

M L Randi¹, E Ruzzon, F Tezza, F Tezza, E Pacquola, F Fabris

Affiliation

¹ Department of Medical and Surgical Sciences, Internal Medicine, University of Padua Medical School, Padua, Italy. [email protected]

PMID: 16517989

Abstract

A 64-year-old female with IgGk monoclonal components (total 45 g/l) and 30% abnormal plasma cells and plasmoblasts in bone marrow is reported. After the identification of leishmania in the bone marrow, liposomal amphotericin B was used and a progressive resolution of the gammopathy was documented.

Publication types

Case Reports

MeSH terms

Amphotericin B / therapeutic use*
Antiprotozoal Agents / therapeutic use*
Bone Marrow Diseases / diagnosis
Bone Marrow Diseases / drug therapy
Bone Marrow Diseases / parasitology*
Diagnosis, Differential
Female
Humans
Immunoglobulin G / blood
Leishmaniasis, Visceral / diagnosis*
Leishmaniasis, Visceral / drug therapy
Liposomes
Middle Aged
Paraproteinemias / blood

Substances

Antiprotozoal Agents
Immunoglobulin G
Liposomes
Amphotericin B